Whether ERS can activate NLRP3 inflammasome through the ROS/ERK1 pathway or NF-κB pathway and whether NLRP3 inflammasome can regulate ERS in diabetes deserved to be studied. This evidence concerns the gene NFKB1 and diabetes mellitus.